ANTROQUINONOL
Dead / Cancelled — Cancelled — Section 8 (as of 17 Aug 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 85217861
- Registration number
- 4085058
- Mark type
- Design + words
- Filed
- 14 Jan 2011
- Published for opposition
- 16 Aug 2011
- Registered
- 10 Jan 2012
- Attorney of record
- Steven M. Rabin
Goods and services
- Class 005 — Pharmaceuticals: Adjuvants for medical purposes; Antiallergic medicines; Anti-cancer preparations; Medicinal herbal extracts for medical purposes; Pharmaceutical and medicinal preparations and substances for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical and medicinal preparations for the treatment of brain diseases or disorders and autoimmune diseases or disorders; Dietary and nutritional supplements for medical use; Dietary supplements for treating fatigue or liver support; Animal feed additive for use as a nutritional supplement for medical purposes; Dietary supplements for human consumption or for animals; Nutritional additives for medical purposes for use in foods for human consumption or for animals; Animal feed supplements; Dietary pet supplements in the form of pet treats; Fungi preparations for medical or veterinary use for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Pharmaceutical preparations and substances for veterinary purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Chemical preparations for medicinal purposes for treating disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, ocular disorders, brain diseases or disorders, autoimmune diseases or disorders, or bone diseases, for use in dermatology, oncology, hematology and ophthalmology and for gastroenterological disorders or liver ailments; Cardiovascular pharmaceuticals; Cardiovascular treatment preparations; Pharmaceutical preparations for the treatment of kidney diseases
Owner
- GOLDEN BIOTECHNOLOGY CORPORATION, Taipei County 2514, TW
- GOLDEN BIOTECHNOLOGY CORPORATION, Taipei County 2514, TW
- GOLDEN BIOTECHNOLOGY CORPORATION, Taipei County 2514, TW
Prior registrations
Prosecution history
- 17 Aug 2018 — CANCELLED SEC. 8 (6-YR)
- 10 Jan 2017 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 10 Jan 2012 — REGISTERED-PRINCIPAL REGISTER
- 07 Dec 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 06 Dec 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 28 Nov 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 17 Nov 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 10 Nov 2011 — USE AMENDMENT FILED
- 16 Nov 2011 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Nov 2011 — TEAS STATEMENT OF USE RECEIVED
- 11 Oct 2011 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 16 Aug 2011 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 16 Aug 2011 — PUBLISHED FOR OPPOSITION
- 14 Jul 2011 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 06 Jul 2011 — APPROVED FOR PUB - PRINCIPAL REGISTER